<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">Clin Cancer Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Clinical cancer research : an official journal of the American Association for Cancer Research</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">1078-0432</issn>
        <issn pub-type="epub">1557-3265</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC9582036</article-id>
        <article-id pub-id-type="pmcid-ver">PMC9582036.1</article-id>
        <article-id pub-id-type="pmcaid">9582036</article-id>
        <article-id pub-id-type="pmcaiid">9582036</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1801567</article-id>
        <article-id pub-id-type="pmid">35443055</article-id>
        <article-id pub-id-type="doi">10.1158/1078-0432.CCR-21-4183</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1801567</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1801567</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>MAPK pathway genetic alterations are associated with prolonged overall survival in low-grade serous ovarian carcinoma</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Manning-Geist</surname>
              <given-names initials="B">Beryl</given-names>
            </name>
            <xref rid="FN1" ref-type="author-notes">*</xref>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gordhandas</surname>
              <given-names initials="S">Sushmita</given-names>
            </name>
            <xref rid="FN1" ref-type="author-notes">*</xref>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names initials="YL">Ying L.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zhou</surname>
              <given-names initials="Q">Qin</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Iasonos</surname>
              <given-names initials="A">Alexia</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Da Cruz Paula</surname>
              <given-names initials="A">Arnaud</given-names>
            </name>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mandelker</surname>
              <given-names initials="D">Diana</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Roche</surname>
              <given-names initials="KL">Kara Long</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Zivanovic</surname>
              <given-names initials="O">Oliver</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Maio</surname>
              <given-names initials="A">Anna</given-names>
            </name>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Kemel</surname>
              <given-names initials="Y">Yelena</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chi</surname>
              <given-names initials="DS">Dennis S.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>O’Cearbhaill</surname>
              <given-names initials="RE">Roisin E.</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Aghajanian</surname>
              <given-names initials="C">Carol</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Weigelt</surname>
              <given-names initials="B">Britta</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chui</surname>
              <given-names initials="MH">M Herman</given-names>
            </name>
            <xref rid="FN2" ref-type="author-notes">†</xref>
            <xref rid="A6" ref-type="aff">6</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Grisham</surname>
              <given-names initials="RN">Rachel N.</given-names>
            </name>
            <xref rid="FN2" ref-type="author-notes">†</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A2"><label>2</label>Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A3"><label>3</label>Department of Medicine, Weill Cornell Medical College, New York, NY, USA</aff>
        <aff id="A4"><label>4</label>Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A5"><label>5</label>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A6"><label>6</label>Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A7"><label>7</label>Diagnostic Molecular Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA</aff>
        <aff id="A8"><label>8</label>Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA</aff>
        <author-notes>
          <fn fn-type="equal" id="FN1">
            <label>*</label>
            <p id="P1">Equal contribution</p>
          </fn>
          <fn id="FN2">
            <label>†</label>
            <p id="P2">Joint supervision</p>
          </fn>
          <fn fn-type="con" id="FN3">
            <p id="P3">AUTHOR CONTRIBUTIONS</p>
            <p id="P4"><bold>Beryl Manning-Geist, Sushmita Gordhandas:</bold> Conceptualization, Methodology, Formal Analysis, Investigation, Data Curation, Writing- Original Draft, Writing- Review &amp; Editing, Visualization. <bold>Ying Liu:</bold> Conceptualization, Methodology, Writing- Original Draft, Writing- Review &amp; Editing, Supervision, Project Administration. <bold>Qin Zhou, Alexia Iasonos, Arnaud Da Cruz Paula</bold>: Software, Validation, Formal analysis, Investigation, Resources, Data Curation, Writing- Review &amp; Editing, Visualization. <bold>Diana Mandelkar</bold>: Formal analysis, Investigation, Resources, Data Curation, Writing- Review &amp; Editing, Visualization. <bold>Kara Long Roche, Dennis Chi, Oliver Zivanovic, Roisin O’Cearbhaill, Carol Aghajanian:</bold> Methodology, Writing- Review &amp; Editing, Visualization. <bold>Anna Maio, Yelena Kemel</bold>: Formal analysis, Investigation, Resources, Data Curation. <bold>Britta Weigelt, M Herman Chui, Rachel Grisham:</bold> Conceptualization, Methodology, Data Curation, Writing- Original Draft, Writing- Review &amp; Editing, Visualization, Supervision, Project administration.</p>
          </fn>
          <corresp id="CR1"><bold>Corresponding author:</bold> Rachel N. Grisham, MD, Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, Tel. 646-888-4653, <email>grishamr@mskcc.org</email></corresp>
          <fn fn-type="COI-statement" id="FN4">
            <p id="P37"><bold>Conflict of interest statement:</bold> Outside the submitted work, B Weigelt reports ad hoc membership of the scientific advisory board of Repare Therapeutics; YL Liu reports research funding from GSK and AstraZeneca; MH Chui reports an honorarium from Roche and research funding from PaigeAI; RE O’Cearbhaill reports honoraria from GSK, Bayer, Regeneron, SeaGen, Fresenius Kabi, and Curio; R Grisham reports honoraria from GSK, AstraZeneca, Natera, Springworks, Corcept, MJH, and PER. DS Chi reports personal fees from Apyx Medical, Verthermia Inc., Biom ‘Up, and AstraZeneca, as well as recent or current stock/options ownership of Apyx Medical, Verthemia, Intuitive Surgical, Inc., TransEnterix, Inc., Doximity, Moderna, and BioNTech SE.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>14</day>
          <month>10</month>
          <year>2022</year>
        </pub-date>
        <volume>28</volume>
        <issue>20</issue>
        <issue-id pub-id-type="pmc-issue-id">419503</issue-id>
        <fpage>4456</fpage>
        <lpage>4465</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>07</day>
              <month>05</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>14</day>
              <month>04</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>14</day>
              <month>04</month>
              <year>2023</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-13 17:25:15.503">
              <day>13</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1801567.pdf"/>
        <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" xlink:title="editorial" journal-id="Transl Cancer Res" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC10894346">
          <article-title>Current concept of low-grade serous ovarian carcinoma</article-title>
          <volume>13</volume>
          <issue>1</issue>
          <date>
            <day>25</day>
            <month>1</month>
            <year>2024</year>
          </date>
          <fpage>6</fpage>
          <lpage>10</lpage>
          <source>Translational Cancer Research</source>
          <pub-id pub-id-type="doi">10.21037/tcr-23-1161</pub-id>
          <pub-id pub-id-type="pmcid">PMC10894346</pub-id>
          <pub-id pub-id-type="pmid">38410232</pub-id>
        </related-article>
        <abstract id="ABS1">
          <sec id="S1">
            <title>Purpose:</title>
            <p id="P5">To characterize the somatic mutational landscape, investigate associations between genetic alterations and clinical outcomes, and determine the prevalence of pathogenic germline mutations in low-grade serous ovarian carcinomas (LGSCs).</p>
          </sec>
          <sec id="S2">
            <title>Experimental design:</title>
            <p id="P6">Patients with LGSC tumors that underwent panel-based sequencing of up to 505 genes were identified. Data on somatic and germline mutations, copy number alterations, and clinicopathologic features, including age at diagnosis, platinum sensitivity, and overall survival (OS), were collected.</p>
          </sec>
          <sec id="S3">
            <title>Results:</title>
            <p id="P7">Following central pathology re-review, 119 patients with LGSC were identified for analysis. One hundred ten (92%) had advanced-stage disease (stages III/IV). Somatic <italic toggle="yes">KRAS</italic> (33%), <italic toggle="yes">NRAS</italic> (11%), <italic toggle="yes">EIF1AX</italic> (10%), and <italic toggle="yes">BRAF</italic> (11%) alterations were the most common; mitogen-activated protein kinase (MAPK) pathway alterations were found in 60% (n=71) of LGSCs. <italic toggle="yes">KRAS</italic> mutations were significantly associated with age at diagnosis &gt;50 years (p=0.02) and platinum-sensitive disease (p=0.03). On multivariate analysis, MAPK pathway alterations (p=0.02) and platinum sensitivity (p=0.005) were significantly associated with improved OS. Seventy-nine patients (66%) underwent germline genetic testing; 7 pathogenic germline mutations, including 1 bi-allelic <italic toggle="yes">MUTYH</italic> mutation (c.1187G&gt;A (p.Gly396Asp)) and 6 mono-allelic alterations, were identified. Somatic loss of the wildtype allele (loss of heterozygosity) in the tumor at the locus of the germline mutation was only observed in the bi-allelic <italic toggle="yes">MUTYH</italic> mutation carrier. There were no germline <italic toggle="yes">BRCA1/2</italic> mutations.</p>
          </sec>
          <sec id="S4">
            <title>Conclusions:</title>
            <p id="P8">This study showed MAPK pathway alterations in LGSC, including <italic toggle="yes">KRAS</italic> mutations, are independently associated with platinum sensitivity and prolonged survival. Germline data, which were limited, identified few pathogenic germline mutations in patients with LGSC.</p>
          </sec>
        </abstract>
        <kwd-group>
          <kwd>Low-grade serous ovarian carcinoma</kwd>
          <kwd>Molecular</kwd>
          <kwd>Germline</kwd>
          <kwd>BRCA</kwd>
          <kwd>Somatic</kwd>
        </kwd-group>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
